Scholarlink

Background <p>Tuberculosis-diabetes mellitus (TB-DM) multimorbidity significantly increases the risk of multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB). Early risk stratification tools for this high-risk population remain lacking.</p> Objective <p>To develop and validate an interpretable machine learning (ML) model for predicting MDR/RR-TB in patients with TB-DM multimorbidity, and to identify key predictive factors using explainable artificial intelligence.</p> Methods <p>This dual-center retrospective study enrolled 245 patients with TB-DM multimorbidity from January 2019 to December 2022. Seven machine learning algorithms were constructed and validated with 10-fold cross-validation. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC), accuracy, precision, recall, F1-score, calibration curve, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) was applied to identify critical predictive factors.</p> Results <p>The random forest (RF) model achieved the optimal performance, with an AUC-ROC of 0.818, accuracy of 0.806, precision of 0.688, recall of 0.611, and F1-score of 0.647; the moderate recall indicates a considerable false-negative rate (FNR) , supporting its use as a triage tool rather than a stand-alone diagnostic test. Calibration and DCA confirmed robust predictive reliability and substantial clinical net benefit within a clinically relevant threshold range of 0.06–0.80. SHAP analysis identified the symptom-to-diagnosis interval, tuberculosis (TB) treatment history, treatment adherence, pulmonary cavitation, and smoking history as the top five critical predictors.</p> Conclusion <p>The interpretable RF model accurately and reliably predicts the risk of MDR/RR-TB in patients with TB-DM multimorbidity. The symptom-to-diagnosis interval is the most crucial risk factor. This model can assist clinical triage, early intervention, and personalized management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Explainable prediction of MDR/RR-TB in tuberculosis-diabetes mellitus multimorbidity: a machine learning model developed and validated in a dual-center study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Xinxin Zhong,
  • Kuan Liu,
  • Jiujin Zhang,
  • Xinhua Tang,
  • Tao Lu,
  • Qiqi Chen,
  • Jianzhi Pang,
  • Rongjun Chen,
  • Bingrou Li,
  • Siyuan Ding,
  • Libing Ma

摘要

Background

Tuberculosis-diabetes mellitus (TB-DM) multimorbidity significantly increases the risk of multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB). Early risk stratification tools for this high-risk population remain lacking.

Objective

To develop and validate an interpretable machine learning (ML) model for predicting MDR/RR-TB in patients with TB-DM multimorbidity, and to identify key predictive factors using explainable artificial intelligence.

Methods

This dual-center retrospective study enrolled 245 patients with TB-DM multimorbidity from January 2019 to December 2022. Seven machine learning algorithms were constructed and validated with 10-fold cross-validation. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC-ROC), accuracy, precision, recall, F1-score, calibration curve, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) was applied to identify critical predictive factors.

Results

The random forest (RF) model achieved the optimal performance, with an AUC-ROC of 0.818, accuracy of 0.806, precision of 0.688, recall of 0.611, and F1-score of 0.647; the moderate recall indicates a considerable false-negative rate (FNR) , supporting its use as a triage tool rather than a stand-alone diagnostic test. Calibration and DCA confirmed robust predictive reliability and substantial clinical net benefit within a clinically relevant threshold range of 0.06–0.80. SHAP analysis identified the symptom-to-diagnosis interval, tuberculosis (TB) treatment history, treatment adherence, pulmonary cavitation, and smoking history as the top five critical predictors.

Conclusion

The interpretable RF model accurately and reliably predicts the risk of MDR/RR-TB in patients with TB-DM multimorbidity. The symptom-to-diagnosis interval is the most crucial risk factor. This model can assist clinical triage, early intervention, and personalized management.